Navigation Links
March of Dimes awards $250,000 prize to scientists unraveling the causes of muscular dystrophy
Date:5/2/2009

BALTIMORE, MAY 3, 2009 Two scientists whose work has led to new and better ways to diagnose and potentially treat muscular dystrophy have been chosen to receive the 2009 March of Dimes Prize in Developmental Biology.

Kevin P. Campbell, Ph.D. and Louis M. Kunkel, Ph.D., will share the 2009 March of Dimes Prize for their pioneering work identifying the genes and proteins that cause muscular dystrophy, a disorder in which the muscles progressively degenerate. More than 250,000 Americans are affected by the nine forms of muscular dystrophy and other related neuromuscular disorders. Among this group are facioscapulohumeral muscular dystrophy and limb girdle muscular dystrophy, as well as childhood conditions such as Duchenne and Becker muscular dystrophies and congenital muscular dystrophy.

The March of Dimes Prize is a $250,000 cash award and a silver medal in the design of the Roosevelt dime, in honor of President Franklin Delano Roosevelt, who founded the March of Dimes. The Prize will be awarded to Dr. Campbell and Dr. Kunkel at a gala black tie dinner and ceremony at the InterContinental Harbor Court here. CBS sportscaster Greg Gumbel, member of the March of Dimes national Honorary Board of Trustees, will host the ceremony.

"Dr. Campbell and Dr. Kunkel have provided crucial insights into how muscular dystrophies develop the critical step needed to develop diagnostic tools and potential treatments," said Michael Katz, MD, senior vice president for Research and Global Programs at the March of Dimes. "Based on their pioneering research, physicians all over the world now are better able to help families and children affected by these disorders. Currently, there are several promising clinical trials of new treatments in progress based on the achievements of these two scientists."

Dr. Campbell, a Howard Hughes Medical Institute investigator, is professor and head of Molecular Physiology and Biophysics at the University of Iowa Roy J. and Lucille A. Carver College of Medicine. He is also the Roy J. Carver Chair of Molecular Physiology and Biophysics and Director of the Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center. His work unraveled the molecular mechanisms of muscular dystrophies.

Dr. Kunkel, also a Howard Hughes Medical Investigator, is professor of Pediatrics and Genetics at Harvard Medical School as well as Director of the Program in Genomics at The Children's Hospital in Boston, Massachusetts. More than 20 years ago, Dr. Kunkel identified dystrophin, the gene encoding the protein that is altered in boys with Duchenne and Becker forms of muscular dystrophy.

The March of Dimes Prize in Developmental Biology has been awarded annually since 1996 to investigators whose research has profoundly advanced the science that underlies the understanding of birth defects. The March of Dimes Foundation created the Prize as a tribute to Dr. Jonas Salk, who received Foundation support for his work to create a polio vaccine.

Also on May 3, Dr. Campbell and Dr. Kunkel will deliver the Fourteenth Annual March of Dimes Prize Lectures at the Baltimore Convention Center during the 2009 Annual Meeting of the Pediatric Academic Societies.


'/>"/>

Contact: Elizabeth Lynch
elynch@marchofdimes.com
914-997-4286
March of Dimes Foundation
Source:Eurekalert  

Related biology news :

1. Roberta A. Pagon receives lifetime award in genetics from March of Dimes
2. AGU journal highlights -- March 25, 2009
3. Highlights from the March editions of ESA journals
4. American Chemical Societys weekly PressPac -- March 11, 2009
5. Science returns to the Capitol Hill spotlight at March 24 exhibition
6. AGU journal highlights -- March 12, 2009
7. Prominent climate researcher to speak at UH on global warming March 5
8. News from the March 2009 Journal of the American Dietetic Association
9. Story tips from the Departments of Energys Oak Ridge National Lab -- March 2009
10. BioScience tip sheet, March 2009
11. Public Policy Center hosts flood symposium March 10-12
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
March of Dimes awards $250,000 prize to scientists unraveling the causes of muscular dystrophy
(Date:11/22/2016)... Minn. , Nov. 22, 2016   MedNet ... supports the entire spectrum of clinical research, is pleased ... Medical LiveWire Healthcare and Life Sciences Awards ... award caps off an unprecedented year of recognition and ... trials for over 15 years. iMedNet ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Public Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is ... analysis for Private Biobanks shows the highest Compounded Annual Growth ... region during the analysis period 2014-2020. ... CAGR of 9.95% followed by Europe ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, ... developing therapeutics focused on the gut microbiome, today ... of 25,000,000 shares of its common stock and ... stock at a price to the public of ... to Synthetic Biologics from the offering, excluding the ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... , Dec. 2, 2016 Amgen (NASDAQ: ... ) today announced the submission of a Marketing Authorization Application ... a biosimilar candidate to Avastin ® (bevacizumab). The companies ... to the EMA. "The submission of ABP ... seeks to expand our oncology portfolio," said Sean E. ...
(Date:12/2/2016)... ... , ... ACEA Biosciences, Inc. announced today that it will be presenting updated ... World Conference on Lung Cancer 2016, taking place in Vienna, Austria December 3rd-8th. ... for AC0010 in patients with advanced non-small cell lung cancer harboring the EGFR T790M ...
(Date:12/2/2016)... ... December 01, 2016 , ... ... (CSS) and the popularity of US Single Day Events (SDE) to organize a ... Summer 2018, in Raleigh, NC. Topics of the pharmaceutical and life sciences industry ...
(Date:12/2/2016)... IL (PRWEB) , ... December 01, 2016 , ... ... to congratulate long-term client Nanowear on their recent FDA Class II 510(k) clearance ... cleared a significant hurdle in commercializing remote cardiac monitoring devices that rely on ...
Breaking Biology Technology: